AI assistant
Abbott India Ltd. — Regulatory Filings 2021
Jun 14, 2021
61121_rns_2021-06-14_f7117be6-99f0-4a3c-87ad-3ca586a7ffcd.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
==> picture [104 x 103] intentionally omitted <==
Abbott India Limited Registered Office: Tel: (91-22) 5046 1000/2000 Godrej BKC, Plot C-68,”G”Block, 3, Corporate Park, Fax : (91-22) 5016 9400 15-16th Floor, Bandra-Kurla Complex, Sion Trombay Road, E-mail : [email protected] Near MCA Club, Bandra (E), Mumbai - 400 071.India Website : www.abbott.co.in Mumbai - 400 051. India CIN: L24239MH1944PLC007330
BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 001
June 14, 2021
Scrip Code: 500488
Dear Sirs,
Sub: Intimation under Regulation 23 (9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed, disclosure of related party transactions on a consolidated basis, in the format specified in the Accounting Standards for the year ended March 31, 2021.
The above disclosure is also available on the website of the Company i.e. www.abbott.co.in
This is for your information and record.
Kindly acknowledge the receipt of the same.
Thank you.
Yours faithfully,
Abbott India Limited
==> picture [69 x 55] intentionally omitted <==
Krupa Anandpara Company Secretary Membership No.: ACS 16536
Encl: a/a
ABBOTT INDIA LIMITED
DISCLOSURE OF RELATED PARTY TRANSACTIONS FOR THE FINANCIAL YEAR ENDED MARCH 31, 2021
A) Parties where control exists :
Ultimate Holding Company : Abbott Laboratories, USA Holding Company : Abbott Capital India Ltd., UK
B) Other related parties with whom transactions have taken place during the year : I) Fellow subsidiaries : British Colloids Ltd., U.K. Abbott Healthcare Products Ltd., U.K Abbott Healthcare Private Ltd., India Abbott International LLC, USA Abbott Products Operations AG., Switzerland Abbott Laboratories (Singapore) Pte Ltd., Singapore Abbott GmbH, Germany Alere Medical Private Limited, India Abbott Laboratories S.A., Switzerland Abbott Laboratories S.A., Dubai Abbott Laboratories Services LLC, Sri Lanka Branch St Jude Medical India Private Limited, India
II) Key Management personnel and Independent directors:
Mr. Anil Joseph, Managing Director (w.e.f. July 1, 2020)
Mr. Ambati Venu, Non-executive Director (ceased to be the Managing Director effective close of business hours on February 29, 2020) Mr. Munir Shaikh, Chairman
Mr. Rajiv Sonalker, Whole-Time Director
Mr. Krishna Mohan Sahni, Independent Director (ceased to be the Director effective close of business hours on October 28, 2019)
Ms. Anisha Motwani, Independent Director (w.e.f. April 25, 2018) Mr. Sudarshan Jain, Independent Director (w.e.f. April 1, 2019) Ms. Shalini Kamath, Independent Director (w.e.f. October 29, 2019)
C) Transactions during the year :
I) Transactions with the Holding Company during the year
| I) Transactions with the Holding Company during the year (Rupees in Crores) |
||
| For the year ended March 31, 2021 |
For the year ended March 31, 2020 |
|
| Abbott Capital India Ltd., UK Remittance of dividend |
267.98 | 69.67 |
II) Transactions with Fellow Subsidiaries during the year
i) Remittance of dividend :
| For the year ended March 31, 2021 |
For the year ended March 31,2020 |
|
|---|---|---|
| British Colloids Ltd., U.K. Remittance of dividend Abbott Healthcare Products Ltd., U.K. Remittance of dividend |
36.75 93.62 |
9.56 24.34 |
| ii) Sales to fellow subsidiaries : | ||
| For the year ended March 31, 2021 |
For the year ended March 31, 2020 |
|
| Abbott Healthcare Private Ltd., India Sales of stock-in-trade Sales of raw materials Abbott Products Operations AG., Switzerland Sales of stock-in-trade Abbott Laboratories Services LLC, Srilanka Branch Sale of capital goods |
60.94 0.74 - 0.02 |
56.86 47.12 0.86 - |
| iii) Purchases from fellow subsidiaries : | ||
| For the year ended March 31, 2021 |
For the year ended March 31, 2020 |
|
| Abbott Healthcare Private Ltd., India Purchase of raw materials Purchase of stock-in-trade Abbott Products Operations AG., Switzerland Purchase of raw materials Purchase of stock-in-trade Alere Medical Private Limited, India Purchase of capital goods |
0.07 69.53 316.48 84.12 0.01 |
4.92 145.06 297.28 80.04 - |
ABBOTT INDIA LIMITED
DISCLOSURE OF RELATED PARTY TRANSACTIONS FOR THE FINANCIAL YEAR ENDED MARCH 31, 2021
| iv) Other expenses to fellow subsidiaries : (Rupees in Crores) |
iv) Other expenses to fellow subsidiaries : (Rupees in Crores) |
iv) Other expenses to fellow subsidiaries : (Rupees in Crores) |
iv) Other expenses to fellow subsidiaries : (Rupees in Crores) |
iv) Other expenses to fellow subsidiaries : (Rupees in Crores) |
|---|---|---|---|---|
| For the year ended March 31, 2021 |
For the year ended March 31, 2020 |
|||
| Abbott Healthcare Private Ltd., India Shared and support services Promotional expenses Conversion charges Payment of lease liabilities Finance costs Electricity and communication expenses Alere Medical Private Limited, India Promotional expenses |
53.07 0.88 15.64 33.16 10.69 0.92 0.06 |
10.14 0.63 16.63 32.89 1.98 0.72 0.06 |
||
| _In the previous year, the Company adopted Ind AS 116 'Leases', with the date of initial application as April 1, 2019._ v) Deposit to fellow subsidiary :* |
||||
| For the year ended March 31, 2021 |
For the year ended March 31, 2020 |
|||
| Abbott Healthcare Private Ltd., India Interest free additional security deposit paid |
0.16 | - | ||
| vi) Reimbursements to and from fellow subsidiaries : | ||||
| Reimbursement to | Reimbursement from | |||
| For the year ended March 31, 2021 For the year ended March 31, 2020 |
For the year ended March 31, 2021 For the year ended March 31, 2020 |
|||
| Abbott Healthcare Private Ltd., India Market research and other expenses Abbott International LLC, USA Employee benefits expense, travel and other expenses Abbott Laboratories (Singapore) Pte Ltd., Singapore Employee benefits expense, travel and other expenses Abbott Products Operations AG., Switzerland Employee benefits expense, travel and other expenses Abbott Laboratories S.A., Switzerland Employee benefits expense, travel and other expenses Abbott GmbH, Germany Employee benefits expense, travel and other expenses Abbott Laboratories Services LLC, Sri Lanka Branch Employee benefits expense, travel and other expenses |
0.03 - 0.11 0.28 0.01 0.40 - - - - - - - - |
0.26 0.15 0.00 - 0.14 0.27 - 1.60 0.00 0.10 0.04 0.10 0.29 0.25 |
||
| vii) Income from fellow subsidiaries : | ||||
| For the year ended March 31, 2021 For the year ended March 31, 2020 |
||||
| Abbott Healthcare Private Ltd., India Shared and support services (Refer Note 25 (b)) Rent income (Refer Note 25) Abbott Products Operations AG., Switzerland Shared and support services (Refer Note 25 (b)) Abbott Laboratories S.A., Dubai Shared and support services (Refer Note 25 (b)) Abbott Laboratories (Singapore) Pte Ltd., Singapore Shared and support services (Refer Note 25 (b)) St Jude Medical India Private Limited, India Shared and support services (Refer Note 25 (b)) Alere Medical Private Limited, India Shared and support services (Refer Note 25 (b)) |
51.72 16.26 1.15 1.15 2.98 3.71 1.18 1.27 1.18 1.27 1.23 0.61 0.18 - |
|||
| viii) Lease liabilities from fellow subsidiary : | ||||
| For the year ended March 31, 2021 For the year ended March 31, 2020 |
||||
| Abbott Healthcare Private Ltd., India Recognition of lease liabilities* |
- 134.55 |
*In the previous year, the Company adopted Ind AS 116 'Leases', with the date of initial application as April 1, 2019.
| For the year ended March 31, 2021 |
For the year ended March 31, 2020 |
||
| Mr. Munir Shaikh, Chairman | 0.15 - 0.17 0.15 0.15 |
0.11 0.09 0.14 0.12 0.06 |
|
| Mr. Krishna Mohan Sahni, Independent Director (ceased to be the Director effective close of business hours on October 28, 2019) |
|||
| Ms. Anisha Motwani, Independent Director (w.e.f. April 25, 2018) Mr. Sudarshan Jain, Independent Director (w.e.f. April 1, 2019) Ms. Shalini Kamath, Independent Director (w.e.f. October 29, 2019) |
|||
| As at March 31, 2021 |
As at March 31, 2020 |
||
| Trade payable to fellow subsidiaries (Refer Note 20) Abbott Products Operations AG., Switzerland Abbott Healthcare Private Ltd., India Abbott Laboratories (Singapore) Pte Ltd., Singapore Abbott International LLC, USA Lease Liabilities to fellow subsidiary (Refer Note 5) Abbott Healthcare Private Ltd., India Other payable to fellow subsidiary (Refer Note 21) Abbott Healthcare Private Ltd., India Trade receivables from fellow subsidiaries (Refer Note 10) Abbott Healthcare Private Ltd., India Abbott Products Operations AG., Switzerland Other receivables from fellow subsidiaries (Refer Note 14) Abbott Products Operations AG., Switzerland Abbott Healthcare Private Ltd., India Abbott Laboratories Services LLC, Sri Lanka Branch Abbott International LLC, USA Abbott Laboratories S.A., Dubai Abbott Laboratories (Singapore) Pte Ltd., Singapore Abbott GmbH, Germany St Jude Medical India Private Limited, India Alere Medical Private Limited, India Loan and deposit to fellow subsidiaries Abbott Healthcare Private Ltd., India (Refer Note 5 and 6) |
91.21 8.93 - 0.08* |
86.31 14.69 0.03 - |
|
| 100.22 | 101.03 | ||
| 110.71 | 133.18 | ||
| 110.71 | 133.18 | ||
| 0.45 | |||
| 0.45 | |||
| 0.45 | 0.45 | ||
| 9.38 - |
24.77 0.26 |
||
| 9.38 | 25.03 | ||
| 0.53 4.65 - 4.70 0.20 0.20 - 0.23 0.19 |
0.59 0.66 0.02 5.36 0.20 0.23 0.11 0.67 - |
||
| 10.70 | 7.84 | ||
| 14.84 | 14.77 |